{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T17:11:52Z","timestamp":1773681112211,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1995,9,1]],"date-time":"1995-09-01T00:00:00Z","timestamp":809913600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1995,9,1]],"date-time":"1995-09-01T00:00:00Z","timestamp":809913600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[1995,9]]},"DOI":"10.1007\/bf00873798","type":"journal-article","created":{"date-parts":[[2005,1,7]],"date-time":"2005-01-07T20:03:48Z","timestamp":1105128228000},"page":"181-186","source":"Crossref","is-referenced-by-count":40,"title":["Developing gossypol derivatives with enhanced antitumor activity"],"prefix":"10.1007","volume":"13","author":[{"given":"X. S.","family":"Liang","sequence":"first","affiliation":[]},{"given":"A. J.","family":"Rogers","sequence":"additional","affiliation":[]},{"given":"C. L.","family":"Webber","sequence":"additional","affiliation":[]},{"given":"T. J.","family":"Ormsby","sequence":"additional","affiliation":[]},{"given":"M. E.","family":"Tiritan","sequence":"additional","affiliation":[]},{"given":"S. A.","family":"Matlin","sequence":"additional","affiliation":[]},{"given":"C. C.","family":"Benz","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"BF00873798_CR1","volume-title":"Gossypol: A potential contraceptive for men","year":"1985","unstructured":"Segal SJ (ed): Gossypol: A potential contraceptive for men. Plenum Press, New York, 1985"},{"key":"BF00873798_CR2","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1126\/science.6750791","volume":"218","author":"EE Montamat","year":"1982","unstructured":"Montamat EE, Burgos C, Gerez de Burgos NM, Rovail Le, Blanco A, Segura EL: Inhibitory action of gossypol on enzymes and growth of Trypanosoma cruzi. Science 218:288\u2013289, 1982","journal-title":"Science"},{"key":"BF00873798_CR3","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/0031-6989(86)90023-8","volume":"18","author":"RJ Raldof","year":"1986","unstructured":"Raldof RJ, Deck LM, Royer RE, Vander Jagt DL: Antiviral activities of gossypol and its derivatives against herpes simplex virus type II. Pharmacol Res Commun 18:1063\u20131073, 1986","journal-title":"Pharmacol Res Commun"},{"key":"BF00873798_CR4","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/BF01560692","volume":"18","author":"P Benhaim","year":"1994","unstructured":"Benhaim P, Mathes SJ, Hunt TK, Scheuenstuhl H, Benz CC: Induction of neutrophil Mac-1 integrin expression and Superoxide production by the medicinal plant extract gossypol. Inflammation 18:443\u2013458, 1994","journal-title":"Inflammation"},{"key":"BF00873798_CR5","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0304-3835(84)90021-1","volume":"24","author":"W-W Tso","year":"1984","unstructured":"Tso W-W: Gossypol inhibits Ehrlich Ascites tumor cell proliferation. Cancer Lett 24:257\u2013261, 1984","journal-title":"Cancer Lett"},{"key":"BF00873798_CR6","first-page":"20","volume":"15","author":"PN Rao","year":"1985","unstructured":"Rao PN, Wang Y-C, Lotzova E, Khan AA, Rao SP, Stephens LC: Antitumor effects of gossypol on murine tumors. Cancer Chemother Pharmacol 15:20\u201325, 1985","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF00873798_CR7","first-page":"768","volume":"44","author":"GP Tuszynski","year":"1984","unstructured":"Tuszynski GP, Cossu G: Differential cytotoxic effect of gossypol on human melanoma, colon carcinoma, and other tissue culture cell lines. Cancer Res 44:768\u2013771, 1984","journal-title":"Cancer Res"},{"key":"BF00873798_CR8","first-page":"3754","volume":"49","author":"Y-W Wu","year":"1989","unstructured":"Wu Y-W, Chik CL, Knazek RA: Anin vitro andin vivo study of antitumor effects of gossypol on human SW-13 adrenocortical carcinoma. Cancer Res 49:3754\u20133758, 1989","journal-title":"Cancer Res"},{"key":"BF00873798_CR9","first-page":"6936","volume":"50","author":"JW Jaroszewski","year":"1990","unstructured":"Jaroszewski JW, Kaplan O, Cohen J: Action of gossypol and rhodamine 123 on wild type and multidrug-resistant MCF-7 human breast cancer cells: 31p nuclear magnetic resonance and toxicity studies. Cancer Res 50:6936\u20136943, 1990","journal-title":"Cancer Res"},{"key":"BF00873798_CR10","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1172\/JCI112842","volume":"79","author":"C Benz","year":"1987","unstructured":"Benz C, Hollander C, Keniry M, James TL, Mitchell M: Lactic dehydrogenase isozymes, 31P magnetic resonance spectroscopy, andin vitro antimitochondrial tumor toxicity with gossypol and rhodamine-123. J Clin Invest 79:517\u2013523, 1987","journal-title":"J Clin Invest"},{"key":"BF00873798_CR11","first-page":"293","volume":"79","author":"CJG Chang","year":"1993","unstructured":"Chang CJG, Ghosh PK, Hu YF, Brueggemeier RW, Lin YC: Antiproliferative and antimetastatic effects of gossypol on Dunning prostate cell-bearing copenhagen rats. Res Commun Chem Path Pharm 79:293\u2013312, 1993","journal-title":"Res Commun Chem Path Pharm"},{"key":"BF00873798_CR12","first-page":"1019","volume":"76","author":"MR Flack","year":"1993","unstructured":"Flack MR, Pyle RG, M\u00fcllen NM, Lorenzo B, Wu YW, Knazek RA, Nisula BC, Reidenberg MM: Oral gossypol in the treatment of metastatic adrenal cancer. J Clin Endocrinol Metab 76:1019\u20131024, 1993","journal-title":"J Clin Endocrinol Metab"},{"key":"BF00873798_CR13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0304-3835(91)90198-Q","volume":"56","author":"JM Ford","year":"1991","unstructured":"Ford JM, Hait WN, Matlin SA, Benz CC: Modulation of resistance to alkylating agents in cancer cell by gossypol enantiomers. Cancer Lett 56:85\u201394, 1991","journal-title":"Cancer Lett"},{"key":"BF00873798_CR14","first-page":"305","volume":"76","author":"PP Moh","year":"1992","unstructured":"Moh PP, Li PK, Darby MV, Brueggemeier RW, Lin YC: Characteristics of covalent gossypol binding to microsomal proteins. Res Commun Chem Path Pharm 76:305\u2013322, 1992","journal-title":"Res Commun Chem Path Pharm"},{"key":"BF00873798_CR15","first-page":"402","volume":"59","author":"NG Wang","year":"1979","unstructured":"Wang NG, Lei HP: Antifertility effects of gossypol acetic acid on male rats. Natl Med J Clin 59:402\u2013405, 1979","journal-title":"Natl Med J Clin"},{"key":"BF00873798_CR16","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/BF00685601","volume":"30","author":"RC Stein","year":"1992","unstructured":"Stein RC, Joseph AEA, Matlin SA, Cunningham DC, Ford HT, Coombes RC: A preliminary clinical study of gossypol in advanced human cancer. Cancer Chemother Pharmacol 30:480\u2013482, 1992","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF00873798_CR17","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0165-1110(93)90021-E","volume":"297","author":"A Peyster","year":"1993","unstructured":"Peyster A, Wang YY: Genetic toxicity studies of gossypol. Mutation Res 297:293\u2013312, 1993","journal-title":"Mutation Res"},{"key":"BF00873798_CR18","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/0960-0760(91)90082-G","volume":"38","author":"Y Gu","year":"1991","unstructured":"Gu Y, Li PK, Lin YC, Rikihisa Y, Brueggemeier RW: Gossypolone suppresses progesterone synthesis in bovine luteal cells. J Steroid Biochem Molec Biol 38:709\u2013715, 1991","journal-title":"J Steroid Biochem Molec Biol"},{"key":"BF00873798_CR19","first-page":"27","volume":"72","author":"Y Gu","year":"1991","unstructured":"Gu Y, Lin YC: Suppression of adrenocorticotropic hormone (ACTH)-induced corticosterone secretion in cultured rat adrenocortical cells by gossypol and gossypolone. Res Commun Chem Path Pharm 72:27\u201338, 1991","journal-title":"Res Commun Chem Path Pharm"},{"key":"BF00873798_CR20","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/1043-6618(91)90045-Y","volume":"24","author":"RE Royer","year":"1991","unstructured":"Royer RE, Mills RG, Deck LM, Mertz GJ, Jagt DLV: Inhibition of human immunodeficiency virus type I replication by derivatives of gossypol. Pharmacol Res 24: 407\u2013412, 1991","journal-title":"Pharmacol Res"},{"key":"BF00873798_CR21","first-page":"251","volume":"46","author":"T-S Lin","year":"1993","unstructured":"Lin T-S, Schinazi RF, Zhu J, Birks E, Carbone R, Si Y, Wu K, Huang L, Prusoff WH: Anti-HIV-1 activity and cellular pharmacology of various analogs of gossypol. Biochem Pharmacol 46:251\u2013255, 1993","journal-title":"Biochem Pharmacol"},{"key":"BF00873798_CR22","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0010-7824(88)90025-X","volume":"37","author":"SA Matlin","year":"1988","unstructured":"Matlin SA, Zhou RH, Belenguer A, Tyson RG, Brookes AN: Large-scale resolution of gossypol enantiomers for biological evaluation. Contraception 37:229\u2013237, 1988","journal-title":"Contraception"},{"key":"BF00873798_CR23","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1021\/jo01023a031","volume":"30","author":"RH Haas","year":"1965","unstructured":"Haas RH, Shirley DA: The oxidation of gossypol. II. Formation of gossypolone with ferric chloride. J Org Chem 30:4111\u20134113, 1965","journal-title":"J Org Chem"},{"key":"BF00873798_CR24","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1021\/jo01108a610","volume":"21","author":"DA Shirley","year":"1956","unstructured":"Shirley DA, Sheehan WC: The structure and reactions of gossypol. III. Aliphatic anil derivatives of gossypol. J Org Chem 21:251\u2013252, 1956","journal-title":"J Org Chem"},{"key":"BF00873798_CR25","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1021\/jo01092a038","volume":"24","author":"PW Alley","year":"1959","unstructured":"Alley PW, Shirley DA: Some new anil derivatives of gossypol. J Org Chem 24:1534\u20131536, 1959","journal-title":"J Org Chem"},{"key":"BF00873798_CR26","doi-asserted-by":"crossref","first-page":"128","DOI":"10.5935\/0103-5053.19900028","volume":"1","author":"SA Matlin","year":"1990","unstructured":"Matlin SA, Roshdy SM, Cass QB, Freitas LCG, Longo RL, Malvestiti I: Structural investigations of gossypol Schiff's bases. J Brazilian Chem Soc 1:128\u2013133, 1990","journal-title":"J Brazilian Chem Soc"},{"key":"BF00873798_CR27","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/jhrc.1240071106","volume":"7","author":"SA Matlin","year":"1984","unstructured":"Matlin SA, Zhou RH: Resolution of gossypol: Analytical and preparative HPLC. J High Resolution Chromatogr 7:629\u2013631, 1984","journal-title":"J High Resolution Chromatogr"},{"key":"BF00873798_CR28","first-page":"840","volume":"37","author":"CC Benz","year":"1990","unstructured":"Benz CC, Keniry MA, Ford JM, Townsend AJ, Cox FW, Palayoor S, Matilin SA, Hait WN, Cowan KH: Biochemical correlates of the antitumor and antimitochondrial properties of gossypol enantiomers. Mol Pharmacol 37:840\u2013847, 1990","journal-title":"Mol Pharmacol"},{"key":"BF00873798_CR29","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0090-8258(89)90623-9","volume":"32","author":"V Band","year":"1989","unstructured":"Band V, Hoffer AP, Band H, Rhinehardt AE, Knapp RC, Matlin SA, Aderson DL: Antiproliferative effect of gossypol and its optical isomers on human reproductive cancer cell lines. Gynecol Oncol 32:273\u2013277, 1989","journal-title":"Gynecol Oncol"},{"key":"BF00873798_CR30","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/bjc.1986.205","volume":"54","author":"AEA Joseph","year":"1986","unstructured":"Joseph AEA, Matlin SA, Knox P: Cytotoxicity of enantiomers of gossypol. Br J Cancer 54:511\u2013513, 1986","journal-title":"Br J Cancer"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00873798.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF00873798\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00873798","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00873798.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T17:47:47Z","timestamp":1678556867000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF00873798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,9]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1995,9]]}},"alternative-id":["BF00873798"],"URL":"https:\/\/doi.org\/10.1007\/bf00873798","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,9]]}}}